Talecris Biotherapeutics Overview
- Founded
- 1942
- Status
- Acquired/Merged
- Employees
- 5,400
- Latest Deal Type
- M&A
- Financing Rounds
- 6
- Investments
- 1
Talecris Biotherapeutics General Information
Description
Provider of plasma-derived protein therapies worldwide. The company develops, produces, markets, and distributes therapies for the people suffering from chronic and acute immune deficiency disorders, alpha-1 antitrypsin deficiency, infectious diseases, hemophilia, and severe burns. Its also offers Hyperimmunes, which are antibody preparations for hepatitis, rabies, tetanus, and treatment of Rh negative women pregnant with Rh positive children; and albumin under various brand names, including Plasbumin albumin and Plasmanate plasma protein factor. In addition, the company provides plasma-derived hemostasis products to treat patients who lack the necessary factors for blood clotting and suffer from conditions in which clotting occurs; and PPF-powder for the fermentation of Kogenate.
Contact Information
Formerly Known As
Bayer AG (Blood Plasma Business)
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 4101 Research Commons
- 79 T.W. Alexander Drive
- Durham, NC 27709
- United States
+1 (919) 000-0000
Talecris Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Talecris Biotherapeutics‘s full profile, request access.
Request a free trialTalecris Biotherapeutics Executive Team (9)
Talecris Biotherapeutics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000000 00000 | Self | Chairman & Chief Executive Officer | 000 0000 |
Talecris Biotherapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTalecris Biotherapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Talecris Biotherapeutics‘s full profile, request access.
Request a free trialTalecris Biotherapeutics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000 00 | 20-Nov-2006 | 0000000000 | Other Healthcare Services | 0000000 00000000 |